Skip to main content

Table 2 Clinical manifestations and cytogenetic abnormalities of AML patients stratified by age groups

From: Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia

 

Total patients (n = 325)

Younger AML patients (n = 258)

Older AML patients (n = 57)

p value

Age

46 (16–87)

43 (16–59 years)

69 (60–87 years)

N/A

Gender males (n, %)

164 (53.8%)

134 (53.4%)

30 (55.6%)

0.772

WBC (×109/L) (mean, range)

37.3 (0.1–450.7)

36.5 (0.1–450.7)

39.7 (0.5–316.1)

0.724

Hb (g/L) (mean, range)

78.6 (3.3–138.5)

78.0 (3.3–135)

81.0 (39–138.5)

0.384

Plate (×109/L) (mean, range)

63.5 (2.0–442)

63.1 (2.0–442.0)

65.6 (3.0–376.0)

0.814

Blast in BM (mean, range)

57.4 (20.0–97.2)

58.1 (20.0–97.2)

54.3 (22–93.2)

0.275